Back to User profile » Ms Tatiana Dilla

Papers published by Ms Tatiana Dilla:

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain

Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W

ClinicoEconomics and Outcomes Research 2019, 11:395-403

Published Date: 6 June 2019

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain

Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S

ClinicoEconomics and Outcomes Research 2018, 10:747-759

Published Date: 12 November 2018

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population

Dilla T, Lizan L, Paz S, Garrido P, Avendaño C, Cruz-Hernández JJ, Espinosa J, Sacristán JA

Patient Preference and Adherence 2016, 10:1-7

Published Date: 18 December 2015